BG22820A3 - Метод за получаване на пиразолони-5 - Google Patents

Метод за получаване на пиразолони-5

Info

Publication number
BG22820A3
BG22820A3 BG029509A BG2950974A BG22820A3 BG 22820 A3 BG22820 A3 BG 22820A3 BG 029509 A BG029509 A BG 029509A BG 2950974 A BG2950974 A BG 2950974A BG 22820 A3 BG22820 A3 BG 22820A3
Authority
BG
Bulgaria
Prior art keywords
pyrazolones
obtaining
obtaining pyrazolones
Prior art date
Application number
BG029509A
Other languages
Bulgarian (bg)
English (en)
Inventor
Eike Moeller
Karl Meng
Egbert Wehinger
Harald Horstmann
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2319279A external-priority patent/DE2319279A1/de
Priority claimed from DE2363138A external-priority patent/DE2363138A1/de
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG22820A3 publication Critical patent/BG22820A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
    • C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG029509A 1973-04-17 1974-04-12 Метод за получаване на пиразолони-5 BG22820A3 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2319279A DE2319279A1 (de) 1973-04-17 1973-04-17 Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2363138A DE2363138A1 (de) 1973-12-19 1973-12-19 Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
BG22820A3 true BG22820A3 (bg) 1977-04-20

Family

ID=25764995

Family Applications (2)

Application Number Title Priority Date Filing Date
BG029509A BG22820A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на пиразолони-5
BG026396A BG22394A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на пиразолони /5/

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG026396A BG22394A3 (bg) 1973-04-17 1974-04-12 Метод за получаване на пиразолони /5/

Country Status (21)

Country Link
US (1) US3952008A (da)
JP (1) JPS59512B2 (da)
AR (2) AR207445A1 (da)
BG (2) BG22820A3 (da)
CA (1) CA1048513A (da)
CH (2) CH603593A5 (da)
DD (1) DD113230A5 (da)
DK (1) DK136155C (da)
ES (2) ES425374A1 (da)
FR (1) FR2226171B1 (da)
GB (1) GB1424492A (da)
HK (1) HK55876A (da)
HU (1) HU168591B (da)
IE (1) IE39213B1 (da)
IL (1) IL44627A (da)
LU (1) LU69871A1 (da)
NL (1) NL7405116A (da)
NO (1) NO139439C (da)
PL (1) PL96880B1 (da)
RO (2) RO63750A (da)
SE (1) SE408552B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056533A (en) * 1973-04-17 1977-11-01 Bayer Aktiengesellschaft Pyrazol-5-ones
US4000294A (en) * 1973-04-17 1976-12-28 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2319278C2 (de) * 1973-04-17 1986-02-20 Bayer Ag, 5090 Leverkusen Pharmazeutisches Mittel
USRE30420E (en) * 1973-04-17 1980-10-21 Bayer Aktiengesellschaft Pyrazol-5-ones
DE2427272C3 (de) * 1974-06-06 1981-10-01 Bayer Ag, 5090 Leverkusen 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5585571A (en) * 1978-12-22 1980-06-27 Nippon Synthetic Chem Ind Co Ltd:The Preparation of 1,3-disubstituted-5-pyrazolone
JPH0730031B2 (ja) * 1986-04-02 1995-04-05 日産化学工業株式会社 ２―ピラゾリン―５―オン類の製造法
WO2006094201A2 (en) * 2005-03-02 2006-09-08 La Jolla Pharmaceutical Company Semicarbazide-sensitive amide oxidase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2376380A (en) * 1945-05-22 Preparation of amino pyrazolones
GB636988A (en) * 1947-12-24 1950-05-10 Gevaert Photo Producten Naamlo Improvements in and relating to the production of colour photographic images
US2511231A (en) * 1949-03-26 1950-06-13 Eastman Kodak Co 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography
US2600788A (en) * 1949-06-07 1952-06-17 Eastman Kodak Co Halogen-substituted pyrazolone couplers for color photography
US2672417A (en) * 1949-12-31 1954-03-16 Gevaert Photo Prod Nv Production of color photographic images
NL279140A (da) * 1961-05-31

Also Published As

Publication number Publication date
AR207445A1 (es) 1976-10-08
HK55876A (en) 1976-09-17
IE39213B1 (en) 1978-08-30
RO69408A (ro) 1980-06-15
US3952008A (en) 1976-04-20
LU69871A1 (da) 1974-11-21
FR2226171B1 (da) 1978-07-28
CH603593A5 (da) 1978-08-31
IL44627A (en) 1978-07-31
AU6817574A (en) 1975-10-23
DD113230A5 (da) 1975-05-20
NO139439B (no) 1978-12-04
CA1048513A (en) 1979-02-13
HU168591B (da) 1976-06-28
NL7405116A (da) 1974-10-21
BG22394A3 (bg) 1977-02-20
JPS5012082A (da) 1975-02-07
NO741364L (no) 1974-10-18
DK136155B (da) 1977-08-22
CH605799A5 (da) 1978-10-13
IL44627A0 (en) 1974-06-30
RO63750A (ro) 1980-06-15
ES425374A1 (es) 1976-09-16
FR2226171A1 (da) 1974-11-15
NO139439C (no) 1979-03-14
PL96880B1 (pl) 1978-01-31
DK136155C (da) 1978-01-30
ES447081A1 (es) 1977-06-16
AR207242A1 (es) 1976-09-22
JPS59512B2 (ja) 1984-01-07
GB1424492A (en) 1976-02-11
SE408552B (sv) 1979-06-18
IE39213L (en) 1974-10-17

Similar Documents

Publication Publication Date Title
BG25647A3 (bg) Метод за получаване на пиримидини
SE393172B (sv) Festorgan for langstreckta foremal
BG26387A3 (bg) Метод за получаване на хексахидро- дибензо/вd/ пиран -9-они
RO68025A (ro) Procedeu pentru obtinerea 3-metilmercaptopropionaldehidei
BG21208A3 (bg) Метод за получаване на 1- алилокси-2- хидрокси -3- алкинилами- нопропани
BG21859A3 (bg) Метод за получаване на 7-заместени-5-метил-изофлавонови производни
BG21606A3 (bg) Метод за получаване на производни на пиперазинилхиноксалини
BG27079A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4-оксипиперидин
BG27080A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
BG21856A3 (bg) Метод за получаване на пиримидин-тионотиолфосфоно-кисели естери
BG27081A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
BG22820A3 (bg) Метод за получаване на пиразолони-5
IT1022392B (it) Procedimento per ottenere seletti vamente paraxilolo
BG25997A3 (bg) Метод за получаване на 7- ациламидо- 7- метоксицефалоспорини
BG22404A3 (bg) Метод за получаване на а-аминоацил-3-халоцефалоспорини
BG25989A3 (bg) Метод за получаване на заместени хиноксалиндионови съедадения
SE383359B (sv) Stotvagsforma for schaktugn
BG21849A3 (bg) Метод за получаване на заместени нитробензофенонови производни
BG22381A3 (bg) Метод за получаване на диаминобензофенони
BG21203A3 (bg) Метод за получаване на бифенилови производни
BG22823A3 (bg) Метод за получаване на нитромидазолови съединения
BG21852A3 (bg) Метод за получаване на бензиламини
BG27092A3 (bg) Метод за получаване на n-фосфонометилглицинови триестери
SU455915A1 (ru) Способ получени пирониобата свинца
SU469696A1 (ru) Способ получени 5-галоидзамещенных бензопираниндолинов